Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
TLX

Telix Pharmaceuticals (TLX) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $11.21 +1.8% on the day +11.1% over 12 months 52-week range $6.41 – $12.83

Share price and insider trades

TLX closeInsider buyInsider sale
68101214NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $20,006 on 2026-09-07 · Darren Charlton SmithBought $497,178 on 2026-04-29 · Christian BehrenbruchBought $499,560 on 2026-04-28 · Christian Behrenbruch
Bought, 12 months$1.0M
Sold, 12 months$0
Insiders buying2
Insiders selling0

Telix Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $1.0M and 0 sold $0 of TLX stock on the open market; P/E 112.1 vs. a sector median of 24.7.

TLX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $997K bought (2 trades)$997KQ2 2026Q3 2026: $20K bought (1 trades)$20KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$20K1—0
Q2 2026$997K2—0

Valuation, profit and volume

Pick score 42/100
P/E (trailing)112.1Sector median 24.7
Market value$3.81BBiotechnology
Profit margin3.8%Revenue growth +22.3%
Volume vs. 50-day1.4×Last 5 sessions
Insiders' paper profit−$232KOn all tracked purchases -22.8%

Summary

Over the past 12 months, 2 Telix Pharmaceuticals Ltd insiders reported open-market purchases totaling $1.0M, while 0 insiders reported sales totaling $0.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 14SEC Darren Charlton SmithCFO Buy 2,07113,992 held (+17%) $9.66 $20K +16.0% —
May 6SEC Christian BehrenbruchCEO Buy 34,50020,709,500 held (+0%) $14.48 $500K -22.6% —
May 6SEC Christian BehrenbruchCEO Buy 33,43520,742,935 held (+0%) $14.87 $497K -24.6% —

Insiders at Telix Pharmaceuticals Ltd

InsiderBoughtSoldLast filingScore
Christian BehrenbruchCEO $997K — May 6, 2026 —
Darren Charlton SmithCFO $20K — Sep 14, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

TLX stock: common questions

Are Telix Pharmaceuticals Ltd insiders buying TLX stock?

In the past 12 months, 2 insiders reported open-market purchases of TLX worth $1.0M. The latest was CFO Darren Charlton Smith bought $20K of TLX at $9.66 — first open-market purchase in our records.

Are Telix Pharmaceuticals Ltd insiders selling TLX stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is TLX's P/E ratio?

TLX trades at about 112.1 times trailing earnings, compared with a median of 24.7 for the Health Care sector.

What is TLX's 52-week range?

Over the past year TLX has traded between $6.41 and $12.83. It last closed at $11.21 on Oct 9, 2026.